Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection27
A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients25
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective16
The making of the one pill—Developing single tablet regimens for HIV and for HCV15
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting14
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation13
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants13
Commentary: John C. Martin (1951–2021)12
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts12
A rare complication of coronary vasospasm associated with concomitant use of ergotamine, cobicistat, and darunavir10
Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study10
0.15472888946533